TGF-β3-expressing CD4+CD25−LAG3+ regulatory T cells control humoral immune responses-Reference-Cited by-同舟云学术

TGF-β3-expressing CD4+CD25−LAG3+ regulatory T cells control humoral immune responses

Published:2015-02-19 Issue:1 Volume:6 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Okamura Tomohisa,Sumitomo Shuji^ORCID,Morita Kaoru,Iwasaki Yukiko,Inoue Mariko,Nakachi Shinichiro,Komai Toshihiko,Shoda Hirofumi,Miyazaki Jun-ichi,Fujio Keishi,Yamamoto Kazuhiko

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms7329.pdf

Reference52 articles.

1. Tsokos, G. C. Systemic lupus erythematosus. New Engl. J. Med. 365, 2110–2121 (2011).

2. Linterman, M. A. et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat. Med. 17, 975–982 (2011).

3. Sakaguchi, S. & Powrie, F. Emerging challenges in regulatory T cell function and biology. Science 317, 627–629 (2007).

4. Lim, H. W., Hillsamer, P., Banham, A. H. & Kim, C. H. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J. Immunol. 175, 4180–4183 (2005).

5. Okamura, T., Fujio, K., Sumitomo, S. & Yamamoto, K. Roles of LAG3 and EGR2 in regulatory T cells. Ann. Rheum. Dis. 71, (Suppl 2): i96–100 (2012).

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transforming growth factor-β micro-environment mediated immune cell functions in cervical cancer;International Immunopharmacology;2024-10

2. Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review;Frontiers in Oncology;2024-08-26

3. LAG-3 blockade reactivates the CD8⁺T cell expansion program to re-expand contracted clones in the tumor;2024-07-09

4. SWI/SNF chromatin remodeling factor BAF60b restrains inflammatory diseases by affecting regulatory T cell migration;Cell Reports;2024-07

5. Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization;The Journal of Headache and Pain;2024-06-12